Search
for
Sort by
Research 571–600 of 775
- Role of bulge epidermal stem cells and TSLP signaling in psoriasis
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features
- Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Alopecia areata – Current understanding and management
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- Effects of Periplaneta americana extracts on the growth and proliferation of cutaneous interstitial cells in cutaneous-wound healing
- Ruxolitinib found to cause eyelash growth: a case report
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Mechanisms of autophagy and their implications in dermatological disorders
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Essential Role of STAT3 Signaling in Hair Follicle Homeostasis
- Immune therapies for alopecia areata: evidence and new perspectives
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections